Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence DEAGSEADHEGTHSTKRGHA
Primary information
sequence IDSeq_1204
Peptide sequenceDEAGSEADHEGTHSTKRGHA
CancerPDF_ID CancerPDF_ID1247, CancerPDF_ID8538, CancerPDF_ID9692, CancerPDF_ID10456,
PMID21136997,23667664,21533267,21805675
Protein NameFibrinogen alpha,Fibrinogen alpha,Fibrinogen alpha chain,Fibrinogen alpha chain
UniprotKB Entry NameFIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN
FluidSerum,Serum,Serum,Urine
M/Z2090.90019,2090.9,697.96,2091.892
Charge1,1,3,NA
Mass (in Da)NA,2093.09,NA,NA
fdrNA,NA,NA,NA
Profiling TechniqueLC-MS,MALDI-TOF,LC-MS,MALDI-TOF
Peptide Identification techniqueLC-MS-MS/MS,FT-ICR MS/MS + nano-HPLC,LC/MS/MS,MALDI-TOF-MS
Quantification TechniqueLC-ESI-MS,NA,Multiple Reaction Monitoring,NA
Labelled/Label FreeLabel Free,Label Free,Label Free,Label Free
FDRNA,NA,1.49,1
CancerPDF_ID CancerPDF_ID1247, CancerPDF_ID8538, CancerPDF_ID9692, CancerPDF_ID10456,
p-ValueNA,NA,NA,NA
SoftwareMASCOT(v. 2.2.01),MASCOT,MASCOT,NA
Length20,20,20,20
Cancer TypeColorectal cancer,"Breast cancer, Lung cancer, Rectal cancer",Lung adenocarcinoma,Muscle-invasive bladder cancer
DatabaseSwissProt Database,NA,Swissprot Database (57.4),SwissProt Database
ModificationNA,NA,NA,NA
Number of Patients30 patients and 30 healthy controls,"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",62 lung adenocarcinoma and 30 healthy control,751 bladder cancer and 127 control
RegulationNA,NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal",Differentially expressed between cancer vs normal samples
ValidationLeave One out Cross validation,NA,MRM-based validation of 19 candidates,Mann-Whitney tests and areas under receiver-operator characteristic
SensitivityNA,NA,NA,NA
SpecificityNA,NA,NA,NA
AccuracyNA,NA,NA,NA
Peptide AtlasNA
IEDB